Compare $DNA vs $TKNO | Chartloom

Compare

$DNA vs $TKNO

Ginkgo Bioworks Holdings Inc · Alpha Teknova Inc

DNA

Ginkgo Bioworks Holdings Inc

TKNO

Alpha Teknova Inc

Compare $DNA vs $TKNO

Comparing Ginkgo Bioworks Holdings Inc and Alpha Teknova Inc

DNAGinkgo Bioworks Holdings Inc

TKNOAlpha Teknova Inc

DNAGinkgo Bioworks Holdings Inc

Market cap

$810M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-51.5%

YTD performance

49.4%

52W performance

-19.2%

FCF yield

-21.6%

TKNOAlpha Teknova Inc

Market cap

$474M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

9.58x

Rev growth (TTM)

12.3%

YTD performance

126.7%

52W performance

66.5%

FCF yield

-1.6%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

DNA

TKNO

Detailed metrics comparison

DNA

Ginkgo Bioworks Holdings Inc

TKNO

Alpha Teknova Inc

Market Cap

DNA$810M

TKNO$474M

Enterprise Value

DNA$726M

TKNO$481M

Price

DNA$13.00

TKNO$8.84

P/E Ratio

DNAN/A

TKNON/A

P/S Ratio

DNA7.24x

TKNO10.84x

EV/Sales

DNA6.49x

TKNO11.01x

EV/EBITDA

DNA0.00x

TKNO0.00x

P/B Ratio

DNA1.98x

TKNO7.71x

P/FCF Ratio

DNAN/A

TKNON/A

EV/FCF

DNA-4.15x

TKNO-65.43x

PEG Ratio

DNAN/A

TKNON/A

Forward P/E (NTM)

DNAN/A

TKNON/A

Forward P/S (NTM)

DNAN/A

TKNO9.58x

Revenue (TTM)

DNA$112M

TKNO$44M

Revenue Growth (YoY)

DNA-51.5%

TKNO12.3%

Forward Rev Growth

DNA13.4%

TKNO14.4%

Gross Margin (TTM)

DNA77.7%

TKNO34.6%

Operating Margin (TTM)

DNA0.0%

TKNO0.0%

EBITDA Margin (TTM)

DNA-210.7%

TKNO-21.7%

Net Margin (TTM)

DNA-260.0%

TKNO-38.4%

FCF Margin (TTM)

DNA-156.3%

TKNO-16.8%

Net Income (TTM)

DNA$-291M

TKNO$-17M

FCF (TTM)

DNA$-175M

TKNO$-7M

EPS (TTM)

DNA-$4.68

TKNO-$0.31

ROE (TTM)

DNA-6021.0%

TKNO-2494.0%

ROA (TTM)

DNA-2685.0%

TKNO-1653.0%

ROIC (TTM)

DNA-6021.0%

TKNO-2086.0%

Cash

DNA$85M

TKNO$6M

Debt

DNA$0

TKNO$13M

Net Cash/Debt

DNA$85M

TKNO$-7M

Current Ratio (TTM)

DNA4.57x

TKNO4.49x

Quick Ratio (TTM)

DNA4.37x

TKNO3.32x

Debt/Equity (TTM)

DNA0.00x

TKNO0.21x

Debt/Assets (TTM)

DNA0.0%

TKNO0.0%

Interest Coverage (TTM)

DNAN/A

TKNON/A

Net Debt/EBITDA (TTM)

DNA0.00x

TKNO0.00x

Beta

DNA1.69

TKNO0.93

52W Performance

DNA-19.2%

TKNO66.5%

YTD Performance

DNA49.4%

TKNO126.7%

% from 52W High

DNA-28.6%

TKNO-6.8%

% from 52W Low

DNA142.1%

TKNO362.8%

Asset Turnover (TTM)

DNA0.10x

TKNO0.43x

FCF Yield (TTM)

DNA-21.6%

TKNO-1.6%

Earnings Yield (TTM)

DNA-35.9%

TKNO-3.5%

Dividend Yield (TTM)

DNAN/A

TKNON/A

Rule of 40

DNA-207.8

TKNO-4.6

EV/GP/RG

DNA0.42

TKNO2.35

Ticker research

View DNA research View TKNO research

Metric	DNA Ginkgo Bioworks Holdings Inc	TKNO Alpha Teknova Inc
Market & Valuation
Market Cap	$810M	$474M
Enterprise Value	$726M	$481M
Price	$13.00	$8.84
P/E Ratio	N/A	N/A
P/S Ratio	7.24x	10.84x
EV/Sales	6.49x	11.01x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.98x	7.71x
P/FCF Ratio	N/A	N/A
EV/FCF	-4.15x	-65.43x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	9.58x
Revenue & Growth
Revenue (TTM)	$112M	$44M
Revenue Growth (YoY)	-51.5%	12.3%
Forward Rev Growth	13.4%	14.4%
Profitability
Gross Margin (TTM)	77.7%	34.6%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-210.7%	-21.7%
Net Margin (TTM)	-260.0%	-38.4%
FCF Margin (TTM)	-156.3%	-16.8%
Net Income (TTM)	$-291M	$-17M
FCF (TTM)	$-175M	$-7M
EPS (TTM)	-$4.68	-$0.31
ROE (TTM)	-6021.0%	-2494.0%
ROA (TTM)	-2685.0%	-1653.0%
ROIC (TTM)	-6021.0%	-2086.0%
Financial Health
Cash	$85M	$6M
Debt	$0	$13M
Net Cash/Debt	$85M	$-7M
Current Ratio (TTM)	4.57x	4.49x
Quick Ratio (TTM)	4.37x	3.32x
Debt/Equity (TTM)	0.00x	0.21x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.69	0.93
52W Performance	-19.2%	66.5%
YTD Performance	49.4%	126.7%
% from 52W High	-28.6%	-6.8%
% from 52W Low	142.1%	362.8%
Efficiency & Yields
Asset Turnover (TTM)	0.10x	0.43x
FCF Yield (TTM)	-21.6%	-1.6%
Earnings Yield (TTM)	-35.9%	-3.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-207.8	-4.6
EV/GP/RG	0.42	2.35
Ticker research	View DNA research	View TKNO research

Valuation

P/S Ratio

DNA

7.24x

TKNO

10.84x

EV/FCF

TKNO

-65.43x

DNA

-4.15x

Growth & revenue

Revenue Growth TTM

TKNO

12.3%

DNA

-51.5%

Forward Revenue Growth

TKNO

14.4%

DNA

13.4%

Profitability & performance

Gross Margin

DNA

77.7%

TKNO

34.6%

ROE

TKNO

-2494.0%

DNA

-6021.0%

FCF Yield %

TKNO

-1.6%

DNA

-21.6%

52-Week Performance

TKNO

66.5%

DNA

-19.2%

Detailed metrics comparison

DNA

Ginkgo Bioworks Holdings Inc

TKNO

Alpha Teknova Inc

Market Cap

DNA$810M

TKNO$474M

Enterprise Value

DNA$726M

TKNO$481M

Price

DNA$13.00

TKNO$8.84

P/E Ratio

DNAN/A

TKNON/A

P/S Ratio

DNA7.24x

TKNO10.84x

EV/Sales

DNA6.49x

TKNO11.01x

EV/EBITDA

DNA0.00x

TKNO0.00x

P/B Ratio

DNA1.98x

TKNO7.71x

P/FCF Ratio

DNAN/A

TKNON/A

EV/FCF

DNA-4.15x

TKNO-65.43x

PEG Ratio

DNAN/A

TKNON/A

Forward P/E (NTM)

DNAN/A

TKNON/A

Forward P/S (NTM)

DNAN/A

TKNO9.58x

Revenue (TTM)

DNA$112M

TKNO$44M

Revenue Growth (YoY)

DNA-51.5%

TKNO12.3%

Forward Rev Growth

DNA13.4%

TKNO14.4%

Gross Margin (TTM)

DNA77.7%

TKNO34.6%

Operating Margin (TTM)

DNA0.0%

TKNO0.0%

EBITDA Margin (TTM)

DNA-210.7%

TKNO-21.7%

Net Margin (TTM)

DNA-260.0%

TKNO-38.4%

FCF Margin (TTM)

DNA-156.3%

TKNO-16.8%

Net Income (TTM)

DNA$-291M

TKNO$-17M

FCF (TTM)

DNA$-175M

TKNO$-7M

EPS (TTM)

DNA-$4.68

TKNO-$0.31

ROE (TTM)

DNA-6021.0%

TKNO-2494.0%

ROA (TTM)

DNA-2685.0%

TKNO-1653.0%

ROIC (TTM)

DNA-6021.0%

TKNO-2086.0%

Cash

DNA$85M

TKNO$6M

Debt

DNA$0

TKNO$13M

Net Cash/Debt

DNA$85M

TKNO$-7M

Current Ratio (TTM)

DNA4.57x

TKNO4.49x

Quick Ratio (TTM)

DNA4.37x

TKNO3.32x

Debt/Equity (TTM)

DNA0.00x

TKNO0.21x

Debt/Assets (TTM)

DNA0.0%

TKNO0.0%

Interest Coverage (TTM)

DNAN/A

TKNON/A

Net Debt/EBITDA (TTM)

DNA0.00x

TKNO0.00x

Beta

DNA1.69

TKNO0.93

52W Performance

DNA-19.2%

TKNO66.5%

YTD Performance

DNA49.4%

TKNO126.7%

% from 52W High

DNA-28.6%

TKNO-6.8%

% from 52W Low

DNA142.1%

TKNO362.8%

Asset Turnover (TTM)

DNA0.10x

TKNO0.43x

FCF Yield (TTM)

DNA-21.6%

TKNO-1.6%

Earnings Yield (TTM)

DNA-35.9%

TKNO-3.5%

Dividend Yield (TTM)

DNAN/A

TKNON/A

Rule of 40

DNA-207.8

TKNO-4.6

EV/GP/RG

DNA0.42

TKNO2.35

Ticker research

View DNA research View TKNO research

Metric	DNA Ginkgo Bioworks Holdings Inc	TKNO Alpha Teknova Inc
Market & Valuation
Market Cap	$810M	$474M
Enterprise Value	$726M	$481M
Price	$13.00	$8.84
P/E Ratio	N/A	N/A
P/S Ratio	7.24x	10.84x
EV/Sales	6.49x	11.01x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.98x	7.71x
P/FCF Ratio	N/A	N/A
EV/FCF	-4.15x	-65.43x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	9.58x
Revenue & Growth
Revenue (TTM)	$112M	$44M
Revenue Growth (YoY)	-51.5%	12.3%
Forward Rev Growth	13.4%	14.4%
Profitability
Gross Margin (TTM)	77.7%	34.6%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-210.7%	-21.7%
Net Margin (TTM)	-260.0%	-38.4%
FCF Margin (TTM)	-156.3%	-16.8%
Net Income (TTM)	$-291M	$-17M
FCF (TTM)	$-175M	$-7M
EPS (TTM)	-$4.68	-$0.31
ROE (TTM)	-6021.0%	-2494.0%
ROA (TTM)	-2685.0%	-1653.0%
ROIC (TTM)	-6021.0%	-2086.0%
Financial Health
Cash	$85M	$6M
Debt	$0	$13M
Net Cash/Debt	$85M	$-7M
Current Ratio (TTM)	4.57x	4.49x
Quick Ratio (TTM)	4.37x	3.32x
Debt/Equity (TTM)	0.00x	0.21x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.69	0.93
52W Performance	-19.2%	66.5%
YTD Performance	49.4%	126.7%
% from 52W High	-28.6%	-6.8%
% from 52W Low	142.1%	362.8%
Efficiency & Yields
Asset Turnover (TTM)	0.10x	0.43x
FCF Yield (TTM)	-21.6%	-1.6%
Earnings Yield (TTM)	-35.9%	-3.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-207.8	-4.6
EV/GP/RG	0.42	2.35
Ticker research	View DNA research	View TKNO research